시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 비교리스트
생물제제 시장 규모, 점유율, 성장 분석 : 유형별, 약제 클래스별, 치료 용도별, 공급원별, 제조업별, 지역별 - 산업 예측(2025년)
Biologics Market Size, Share, and Growth Analysis, By Type (Tumor Necrosis Factor Inhibitor, T-cell Inhibitor), By Drug Class, By Therapeutic Application, By Source, By Manufacturing, By Region - Industry Forecast 2025-2032
상품코드 : 1681598
리서치사 : SkyQuest Technology Consulting Pvt. Ltd.
발행일 : 2025년 03월
페이지 정보 : 영문 219 Pages
 라이선스 & 가격 (부가세 별도)
US $ 5,300 ￦ 7,668,000
PDF & Excel (Single User License) help
PDF 및 Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,200 ￦ 8,970,000
PDF & Excel (Multiple User License) help
PDF 및 Excel 보고서를 동일 사업장에서 2-5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,100 ￦ 10,272,000
PDF & Excel (Enterprise License) help
PDF 및 Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


한글목차

생물제제 시장 규모는 2023년에 5,113억 달러로 평가되며, 2024년 5,675억 4,000만 달러에서 2032년에는 1조 3,079억 2,000만 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 11.0%로 성장할 전망입니다.

세계 바이오의약품 시장은 생명공학 기술의 발전과 표적치료제에 대한 수요 증가에 힘입어 견고한 성장세를 보이고 있습니다. 생물 유래 의약 화합물인 생물제제는 암, 자가면역질환, 감염성 질환 등 만성질환 치료의 전망을 크게 바꾸어 놓았습니다. 맞춤형의 혁신적인 접근 방식은 환자의 예후를 개선하고 바이오의약품을 현대 의료의 중요한 요소로 자리매김하고 있습니다. 시장 성장의 주요 촉진요인으로는 당뇨병, 관절염과 같은 만성질환의 확산과 효과적인 치료 옵션의 필요성이 대두되고 있다는 점을 꼽을 수 있습니다. 그러나 온도와 환경 조건의 영향을 받아 공급망 전체에 걸쳐 이러한 생물제제의 무결성을 유지하는 것은 여전히 과제로 남아있습니다. 미국 바이오의약품 시장은 지속적인 성장이 예상되며, 삶의 질 향상과 질병 관리에 있으며, 바이오의약품의 유망한 잠재력을 보여주고 있습니다.

목차

서론

조사 방법

개요

시장 역학과 전망

주요 시장 인사이트

생물제제 시장 규모 : 유형별

생물제제 시장 규모 : 약제 클래스별

생물제제 시장 규모 : 치료 용도별

생물제제 시장 규모 : 공급원별

생물제제 시장 규모 : 제조업별

생물제제 시장 규모 : 약 유형별

생물제제 시장 규모 : 구입 방법별

생물제제 시장 규모 : 제형별

생물제제 시장 규모 : 투여 경로별

생물제제 시장 규모 : 최종사용자별

생물제제 시장 규모 : 유통 채널별

생물제제 시장 규모

경쟁 정보

주요 기업 개요

결론과 제안

KSA
영문 목차

영문목차

Biologics Market size was valued at USD 511.3 billion in 2023 and is poised to grow from USD 567.54 billion in 2024 to USD 1307.92 billion by 2032, growing at a CAGR of 11.0% during the forecast period (2025-2032).

The global biologics market has demonstrated robust growth, driven by advancements in biotechnology and the rising demand for targeted therapies. Biologics, pharmaceutical compounds sourced from living organisms, have shifted the landscape of treatment for chronic conditions, including cancer, autoimmune disorders, and infectious diseases. Their tailored and innovative approaches enhance patient outcomes, positioning biopharmaceuticals as critical components in modern healthcare. Key market growth drivers include the escalating prevalence of chronic diseases, such as diabetes and arthritis, necessitating effective treatment options. However, challenges remain in maintaining the integrity of these biologics throughout the supply chain, influenced by temperature and environmental conditions. The US biologics market is set for sustained growth, indicating promising prospects for biopharmaceuticals in improving quality of life and disease management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Biologics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Biologics Market Segments Analysis

Global Biologics Market is segmented by Type, Drug Class, Therapeutic Application, Source, Manufacturing, Drug Type, Mode of Purchase, Dosage Form, Route of Administration, End-Users, Distribution Channel and region. Based on Type, the market is segmented into Tumor Necrosis Factor (TNF) Inhibitor, T-cell Inhibitor, Selective Co-stimulation Modulators, Interleukin-6 (IL-6) or Interleukin-17 Blocker, Interleukin-1 (IL-1) Blocker and B-cell Inhibitor. Based on Drug Class, the market is segmented into Monoclonal Antibody, Recombinant Insulin, Vaccine, Blood Factor, Human Growth Hormone, Erythropoietin, Fusion Protein, Recombinant Enzyme, Interferon, Colony-stimulating Factor, Gene Therapy, Peptide, Botulinum Toxin and Others. Based on Therapeutic Application, the market is segmented into Oncology, Autoimmune/Immunologic Diseases, Metabolic Disorders, Ophthalmic Diseases, Respiratory Disorders, Inflammatory Bowel Diseases (IBDs), Neurological Disorders, Cardiovascular Diseases (CVDs), Musculoskeletal Disorders (MSDs), Infectious Diseases and Others. Based on Source, the market is segmented into Microbial, Mammalian and Others. Based on Manufacturing, the market is segmented into Outsourced and In-House. Based on Drug Type, the market is segmented into Branded Drugs and Generic Drugs. Based on Mode of Purchase, the market is segmented into Prescription Drugs and Over-The-Counter (OTC) Drugs. Based on Dosage Form, the market is segmented into Injection, Tablets and Others. Based on Route of Administration, the market is segmented into Parenteral, Oral and Others. Based on End-Users, the market is segmented into Hospitals, Specialty Clinics, Homecare and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy, Online Pharmacy and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Biologics Market

The rising prevalence of chronic diseases, including cancer, diabetes, and autoimmune disorders, has significantly spurred the demand for innovative biological therapies. These advanced treatments leverage targeted approaches, distinguishing them from traditional chemical-based medications and enhancing their effectiveness. As a result, the biologics market is experiencing substantial growth, driven by the need for more precise and efficient therapeutic options. This trend reflects a broader shift toward personalized medicine, where tailored treatments not only improve patient outcomes but also foster ongoing advancements in biopharmaceutical research and development, further propelling the market forward.

Restraints in the Biologics Market

The biologics market faces significant challenges due to the intricate and expensive processes involved in the development and production of natural products. The stringent regulatory standards in place can limit both the affordability and accessibility of biologic therapies, ultimately hindering market growth. As companies navigate these challenges, the high costs associated with compliance and manufacturing may deter investment and innovation, which could further stifle advancements in biologic treatments. Consequently, the interplay between regulatory demands and production complexities remains a critical restraint for the biologics market, impacting its overall potential and reach in the healthcare industry.

Market Trends of the Biologics Market

The Biologics market is witnessing a significant shift towards personalized medicine, fundamentally transforming therapeutic approaches. This trend emphasizes the development of biologic therapies tailored to the unique genetic profiles and specific disease characteristics of individual patients, leading to more effective and targeted treatments. As a result, innovation in biological sciences is accelerating, with advancements in areas such as monoclonal antibodies, gene therapies, and regenerative medicine. The growing demand for precision therapies is propelling investments and research in this field, expanding the scope and applications of biologics in managing various diseases, thus positioning the market for robust growth in the coming years.

Table of Contents

Introduction

Research Methodology

Executive Summary

Market Dynamics & Outlook

Key Market Insights

Global Biologics Market Size by Type & CAGR (2025-2032)

Global Biologics Market Size by Drug Class & CAGR (2025-2032)

Global Biologics Market Size by Therapeutic Application & CAGR (2025-2032)

Global Biologics Market Size by Source & CAGR (2025-2032)

Global Biologics Market Size by Manufacturing & CAGR (2025-2032)

Global Biologics Market Size by Drug Type & CAGR (2025-2032)

Global Biologics Market Size by Mode of Purchase & CAGR (2025-2032)

Global Biologics Market Size by Dosage Form & CAGR (2025-2032)

Global Biologics Market Size by Route of Administration & CAGR (2025-2032)

Global Biologics Market Size by End-Users & CAGR (2025-2032)

Global Biologics Market Size by Distribution Channel & CAGR (2025-2032)

Global Biologics Market Size & CAGR (2025-2032)

Competitive Intelligence

Key Company Profiles

Conclusion & Recommendations

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기